ANAB Competitors & Alternatives
Compare AnaptysBio Inc with similar stocks in the same industry
Biotechnology
ANAB
Main Stock$53.36
Tradestie Score
52
Market Cap
$894.30M
Revenue Growth
-0.1%
Analyst Upside
+63.2%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$18.92
|
$1.74B | - | 56 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$38.06
|
$1.68B | - | 57 | Compare |
|
MNKD
Mannkind Corporation
|
$3.91
|
$1.65B | - | 51 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$38.43
|
$1.63B | - | 50 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.50
|
$1.57B | - | 51 | Compare |
|
VCEL
Vericel Corporation
|
$45.96
|
$1.56B | 108.2 | 52 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$106.92
|
$1.55B | - | 56 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$35.24
|
$1.55B | 14.5 | 59 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$32.62
|
$1.55B | - | 59 | Compare |
|
NVAX
Novavax Inc
|
$7.32
|
$1.54B | - | 56 | Compare |
More ANAB Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry